| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |